More tools:Markets·Screener·Research·Chat

Alterity Therapeutics Limited American Depositary Shares (ATHE) Financial Statements

Alterity Therapeutics Limited American Depositary Shares
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001SHP8H6
XNAS · usd
4.11▼ 0.39 (-8.67%)
As of 2026-09-10
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close4.50
Day's Range4.11 – 4.46
52-Week Range2.66 – 5.89
Volume56.9K
Avg Volume15.8K
Share Statistics
Shares Outstanding
Employees9
ExchangeXNAS
Listed1992-03-04
Share count as of June 30, 2026
Loading Income Statement…
Key questions about Alterity Therapeutics Limited American Depositary Shares (ATHE)
What is Alterity Therapeutics Limited American Depositary Shares's Market Cap?
Alterity Therapeutics Limited American Depositary Shares's Market Cap is $894.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alterity Therapeutics Limited American Depositary Shares's Enterprise Value?
Alterity Therapeutics Limited American Depositary Shares's Enterprise Value is $868.2M, based on as-reported figures from SEC (XBRL) filings.
What is Alterity Therapeutics Limited American Depositary Shares's Net Income (TTM)?
Alterity Therapeutics Limited American Depositary Shares's Net Income (TTM) is -$16.2M, based on as-reported figures from SEC (XBRL) filings.
What is Alterity Therapeutics Limited American Depositary Shares's Diluted EPS (TTM)?
Alterity Therapeutics Limited American Depositary Shares's Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.
What is Alterity Therapeutics Limited American Depositary Shares's Net Debt?
Alterity Therapeutics Limited American Depositary Shares's Net Debt is -$25.8M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018
Profit or loss [abstract]
Interest income
Other income
Intellectual property expenses
General and administration expenses
Research and development expenses
Other operating expenses
Other gains / (losses)
Loss before income tax expense
Income tax expense
Loss for the year
Other comprehensive loss
Total comprehensive loss for the year
Loss per share (basic and diluted - cents per share) (adjusted) (in AUD per share)